NNDM news

Latest 7 stories · newest Jul 21, 2026

NNDM
Nano settles with activist Murchinson, shuttering proxy battle

Nano Dimension settled a proxy fight filed by Murchinson, which held ~9% ownership, resulting in the immediate withdrawal of an Extraordinary General Meeting bid and a change to the board's composition. This legal agreement resolves the stand-off between the company and shareholder.

NNDM
Nano Dimension terminates HQ lease to save $25M

Nano Dimension is terminating its corporate headquarters lease effective December 31, 2026, to reduce cash burn.

NNDM
Nano Dimension proposes to acquire Infinite Epigenics in all-stock business combination

Nano Dimension has proposed acquiring 100% of Infinite Epigenetics through a reverse merger, with Infinite shareholders receiving Nano stock based on an agreed exchange ratio derived from company valuations. The transaction values Infinite at $890 million and represents a significant M&A activity fo…

NNDM
Nano Dimension shareholders to vote on strategic alternatives and board composition

An extraordinary general meeting scheduled for July 31, 2026 will vote on continuing the company's strategic review process and proposals to amend governance structure and replace three board directors. The shareholder activism signals potential pressure for strategic action or leadership changes at…

NNDM
Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate
NNDM
Nano Dimension sells MarkForged to Stratasys for $42.5M in cash

Nano Dimension agreed to sell its MarkForged subsidiary to Stratasys for $42.5 million in an all-cash transaction expected to close in H2 2026. The sale is expected to reduce Nano Dimension's annualized cash burn by approximately $15 million as part of its Phase 2 strategic plan to monetize product …

NNDM
Nano Dimension Board Rejects Murchinson's Bid to Replace Three Directors

Nano Dimension's Board issued a shareholder letter rejecting Murchinson Ltd.'s amended Schedule 13D filing seeking to replace three directors and gain control of the company's assets without paying a control premium. The company states it is continuing its strategic alternatives review process to ma…

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same NNDM feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/NNDM/newsSTART FREE